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ABSTRACT
Tablet splitting and crushing is a widespread practice among health-care providers and patients
for increasing dose flexibility, or making tablet parts easier to swallow, or allowing cost savings for
medications. However, this practice may be dangerous because some formulations and classes of
drugs are unsuitable for crushing or splitting and may cause significant problems, especially in
drugs with low therapeutic indices. This study was conducted to examine the knowledge, attitudes
and practice of pharmacists toward splitting or crushing oral solid dosage forms (OSDFs) in Palestine. This is a self-administered cross-sectional questionnaire survey involving 300pharmacistswho
work at community pharmacists and hospitals in the West Bank area of Palestine and was conducted during the period May 2013 to August 2013. Data were collected using a pretested questionnaire
consisting of four sections and analyzed using descriptive statistics and correlation. A total of 325
questionnaires were distributed and 300 were completed. About 67.3% of the pharmacists had good
knowledge. Nearly 69% of the pharmacists had a good attitude. There was a positive correlation
(p=0.002, r=0.18) between knowledge and attitude scores among pharmacists. Approximately
83.7% of the pharmacists had good practices. There was a significant difference between practice
and non-practice respondents regarding knowledge score (p=0.037). This study has identified
knowledge, attitude and practice gaps among health-care practitioners, especially among pharmacists. Therefore, improving appropriate knowledge regarding splitting and crushing OSDFs is required by planning and developing programs for local health education purposes.
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lets into capsules with the desired filling
BACKGROUND
weight [1]. This practice is useful for chilOne of the significant current discusdren or older persons; (ii) slowing the titrasions from a medical and legal point of view
tion of the medication to start therapy with
is splitting or crushing oral solid dosage
the lowest possible doses and then starting to
forms (OSDFs). Splitting OSDFs refers to
increase the dose until reaching the desired
the practice of dividing a tablet to provide a
dose to enable toleration of the drug and relower dose of the active ingredient or to obduce the incidence of side effects of certain
tain multiple smaller doses for many purposdrugs, e.g. with beta-blockers such as
es. While crushing tablet refers to the process
metoprolol used post myocardial infarction,
of converting tablets into powder by using
patients cannot tolerate full doses of 50mg
suitable pharmacy tools such as mortar and
and instead are given 12.5mg, then the dose
pestle. These may provide several adwill be increased. The lowest dose available
vantages. Patients usually split tablets for
is 50mg, which necessitates the tablet being
various reasons, such as: (i) providing the
split into quarters to give the wanted dose
patient with the desired dose when the prod[2]. Another example of the benefit of splituct is not available at the required strength,
ting a tablet in slow titration is patients who
e.g. hydrochlorothiazide: the available dose
are taking anticoagulation therapy with waris 25mg and the drug is commonly used in
farin: patients require frequent dose changes
doses of 12.5mg, thus the patient needs to
to stay at an appropriate level of anticoagulasplit the tablet to receive the smaller dose.
tion. Instead of purchasing more than one
Another example is converting atenolol tabstrength, patients resort to purchasing one
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strength and splitting the tablets to adjust the
dose as required [2]; other reasons include
(iii) reducing medication costs; (iv) making
the swallowing of large tablets easier [3-5];
and (v) providing medication dose flexibility
[6, 7]. Regarding crushing tablets, it is an
acceptable method of medication administration for patients with swallowing problems
due to the large size of the capsules or due to
a bad taste or the number of tablets to be administered, and crushing tablets and mixing
them with food is considered a convenient
method of administration to individuals with
memory loss or confusion [8].
It is important to realize the possible effects of tampering with drugs. Altering the
design of dosage forms may cause a change
in the pharmacokinetic and pharmacological
effect of drugs [9]. There are some problems
associated with splitting or crushing OSDFs.
It creates hazards for pharmacists: splitting or
crushing teratogenic drugs or carcinogenic
drugs such as valganciclovir or methotrexate
expose pharmacists to risks via the aerosolization of powder, in a similar way to some
hormones, corticosteroids, mycophenolate
and many other drugs [9]. In fact, powder
dust is one of the major factors that must be
controlled during the manufacturing of
OSDFs, since this factor is responsible of
cross contamination and may cause serious
hazards to operators. Splitting or crushing
OSDFs may have a negative effect on drug
stability; an example of that is nifedipinecoated tablets, as this drug is very lightsensitive when it has been crushed [9]. Proton-pump inhibitors such as omeprazole and
pantoprazole are enteric coated. This coat
protects them from acidic environment of the
stomach. This permits them to reach unchanged the site of absorption. The effect of
the drug coating will be removed by crushing
it and this will lead to decreasing the effect of
the drug in the small intestine [10]. Changes
in bioavailability are another problem associated with crushing OSDFs [9]. These changes may be very significant for drugs with a
narrow therapeutic window such as carbamazepine or digoxin [9]. In fact, one of the major disadvantages of sustained release tablets
is due to the rupture of this design (coat or
matrix) which cause the release of the con-

tent in the gastrointestinal tract (GIT) causing
toxic levels of the active pharmaceutical ingredients.
For drugs that have a problem with their
taste such as ciprofloxacin, clarithromycin
and sertraline, coating is utilized to hide their
unpleasant bitter or anaesthetic taste [9].
Sugar coating, which contains a hard thick
layer, may be used for coating drugs such as
ibuprofen [9]. Film coating, which contains a
thinner layer than sugar, is also used for coating many drugs such as ciprofloxacin,
pseudoephedrine and cefuroxime axetil [9].
So crushing drugs that have a bitter taste may
lead patients to reject taking drugs unless
they are mixed with suitable food or drink
[9]. In fact, clarithromycin is one of the worst
bitter tasting drugs, this drug reaches the salivary gland after being absorbed and distributed. This will result in a strong bitter after
taste that may decrease patient compliance.
Previous research in the world has produced few studies about this issue [11-13]. In
fact, this study is considered to be the first in
Palestine to measure the knowledge, attitudes
and practices of health-care practitioners regarding crushing and/or splitting OSDFs.This
study may increase the awareness of healthcare practitioners toward splitting or crushing
OSDFs, the appropriate decision and the best
way to consider crushing or splitting tablets.
METHODS
Study design and study area
This is a questionnaire-based crosssectional analytical study; it is designed to
measure the attitudes, knowledge and practices of pharmacists toward crushing or splitting OSDFs. Palestine consists of two zones
separated geographically: the West Bank and
the Gaza strip, with a total population of
about three million inhabitants. Nearly 62%
live in the West Bank and 39% live in the
Gaza Strip. The West Bank is divided into
three regions and 11 governorates. The north
area comprises: Jenin, Tulkarm, Nablus, Qalqilya, Tubas and Salfit; the middle area comprises: Jerusalem, Ramallah and Jericho; the
south area comprises: Bethlehem and Hebron
[14].
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This study was conducted in the West
Bank of Palestine from May 2013 until August 2013. The authors acquired a list of the
names of hospitals and their addresses from
the Ministry of Health, and obtained a list of
names of all community pharmacies and their
addresses from the Palestinian Pharmaceutical Association. Based on the list, the authors
visited the following governorates in the
West Bank: Nablus, Jenin, Tulkarm, Qalqilya, Tubas, Ramallah, Bethlehem and Hebron
[14].

Population of the study
The population of the study was pharmacists who work in community pharmacies
and hospitals in the West Bank. Community
pharmacists comprise one of the most important sectors of health-care professionals:
in addition to their role in providing drugs,
they are also considered a source of information about health and drugs. The West
Bank, which is located west of the River Jordan, has a total population of three million
and is divided in to three regions – north,
south and middle – in 11 governorates. There
are 3217 registered pharmacists in the West
Bank and the majority of them work in the
private sector[15]. Others work in hospitals,
clinics, and pharmaceutical industries and
companies.
Sample size calculation and sampling procedure

In this study the convenience samples of
pharmacists from hospitals and community
pharmacies were taken from the visited governorates in the West Bank. Community
pharmacies that were closed or in which the
pharmacist in charge was not present at the
time of the visit were excluded from the
study. Hospitals in which the pharmacist in
charge was not present at the time of the visit
were excluded from the study.
The expected number of pharmacists
who were licensed by the Palestinian Pharmaceutical Association and working within
their field and connected with splitting or
crushing OSDFs was around 1200. Based on
this,
Raosoft
software
(http://www.raosoft.com/samplesize.html)
was used to calculate a suitable sample size

and this was 292 for pharmacists. In order to
minimize erroneous results and increase the
study reliability, the target sample size included 300 samples for pharmacists.
DATA COLLECTION INSTRUMENT
The questions used in the tool had been
developed based on previously published
studies in other countries [7-11, 13, 16-24].
The tool was piloted and tested before the
study was officially carried out. The questionnaire used in the tool consists of four sections: 1. demographic data (gender, age,
workplace, education, place and year of
graduation), 2. practice in splitting/crushing
tablets (5 questions), 3. attitudes (9 questions
answered as yes/no/don't know), and 4.
knowledge (1 on source of information and
14 on specific examples). Attitude was
scored from 0 to 9 points with 'good attitude'
denoted as a score from 6 to 9 points and
'poor attitude' from 0 to 5 points. The
Knowledge score was based on the 14 examples and a score of 8 to 14 was considered
'good knowledge' and 0 to 7 as 'poor
knowledge'.
The internal consistency and validity of
the questionnaire were ensured for the instruments used in our study, namely the attitude scale (nine items, Cronbach’s alpha
=0.76) and theknowledge scale (14 items,
Cronbach’s alpha =0.73). The tool used in
this study had been constructed by the authors and was reviewed and corrected by
three PhD holders in clinical and pharmaceutical sciences that had at least four years of
pharmacy practice to ensure face and content
validity.
Ethical approval
All aspects of the study protocol were
obtained from the Institutional Review Board
(IRB) at An-Najah National University and
the required permission from the Palestinian
Ministry of Health. The authors obtained
verbal consent from the community pharmacists who participated in the study.
Statistical analysis and scoring
Statistical analyses were performed by
using the Statistical Package for the Social
Sciences (SPSS version 16.0). Mean and
standard deviation was computed for contin-
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uous data. Frequencies and percentages were
calculated for categorical variables. Data that
were not normally distributed were expressed
as a median with a range of values (lowerupper quartiles). Data that were not normally
distributed were analyzed by the KruskalWallis or Mann-Whitney U test. Variables
were tested for normality using the Kolmogorov-Smirnov test. Spearman’s correlation
coefficient was used to assess whether there
was a correlation between variables. Categorical variables were compared using Chisquared and Fisher’s exact tests, as applicable. A p-value of less than 0.05 was considered to be statistically significant for all analyses. Internal consistency was assessed using
Cronbach’salpha.
RESULTS

Demographic characteristics
A total of 325 questionnaires were distributed to the hospitals, community pharmacies and primary health-care centers in Palestine. Twenty-five of the questionnaires were
found to be incomplete and were therefore
excluded from the analysis. As shown in the
summary of demographic characteristics in
Table 1, the vast majority of the respondents
were females (71%) and 29% were males.
More than half of the respondents (62.6%)
were working in community pharmacies. The
average age of the participants was 32±9.6
years and the average number of years of
experience was 8.4±9. Majority of the pharmacists (87%) had a bachelor degree. The
majority of the participants (79%) studied at
and graduated from local universities.

Table (1): Demographic characteristic of pharmacists

Variable
Graduation institute
Local institute
Arab institute
Others
Gender
Male
Female
Place of work
Hospital
Primary care
Community pharmacy

Pharmacists N=300
Frequency (%)
237 (79)
43 (14.3)
20 (6.7)
87 (29)
213 (71)
90 (30)
22 (7.33)
188 (62.6)

Age category years

20-29
30-39
40-49
50-59
≤60
Educational level
Bachelor of Science
Master of Science
Age
Mean ±SD
Experience years
Mean ±SD
Knowledge of the respondents about
crushing or splitting OSDFs
The level of knowledge about crushing
or splitting OSDFs, its safety and therapeutic
implications were evaluated using statements

169(56.14)
89(29.5)
19(6.31)
17(5.64)
7(2.32)
261 (87)
39 (13)
32±9.6
8.4±9
shown in Table 2. When the participants
were asked whether extended-release (ER)
solid products should not be split or crushed
because they are planned for drug release in
the intestine not in the stomach, only 29.3%
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correctly answered no. Among the 300 rethe active ingredients. About 62.6% of the
spondents, 94.6% of the pharmacists knew
pharmacists knew that the administration of
that ER formulation consisted of layers or
crushed nifedipine XL® resulted in increased
micro grains with progressive dissolution
toxicity. 60.7% of the pharmacists correctly
time. Respondents were less knowledgeable
agreed that pancreatin tablet should not be
about whether Tegretol 400 mg CR® divicrushed because this will inactivate the active
tabs can be split or not; only 25.7% of the
ingredients. About 29% of the pharmacists
pharmacists agreed with this statement. Only
did not know that antineoplastic drugs should
25% of the pharmacists knew that combinanot be split or crushed because this will extion products in the same tablet will not afpose pharmacists to health risks. Respondents
fect the appropriateness for splitting or crushwere less knowledgeable about whether nifeing OSDFs. In fact, 79.3% of the pharmacists
dipine-coated tablets should not be crushed
correctly disagreed that Tegretol400 mg
because the drug is highly light-sensitive;
CR® divitabs can be crushed. About 87% of
only 27% of the pharmacists agreed with this
the pharmacists knew that baby aspirin cardio
statement. Nearly 80% of the pharmacists
cannot be split because it is enteric coated. In
knew that the administration of crushed enparticular, 11.8% of the pharmacists did not
teric-coated sulfasalazine tablets led to the
know that Lescol XL® (fluvastatin) should
release of the drug too early. Finally, majorinot be crushed or split because it is extended
ty (74.2%) of the pharmacists correctly anrelease, 63.3% of the pharmacists agreed that
swered that the administration of crushed
omeprazole enteric-coated granules should
alendronate may cause oesophageal irritation.
not be crushed because this will inactivate
Table (2): Responses to questions regarding knowledge of pharmacists toward crushing or splitting
oral solid dosage forms (OSDFs).
Variable
K1: Most extended release formulation must not be split or crushed because it
is planned for passing the stomach intact and beginning drug release in the
intestine:
Yes
No
I do not know
K2: Most extended release formulation must not be split or crushed because it
is consisting of layers or micro grains with progressive dissolution time:
Yes
No
I don't know
K3: Tegretol 400 mg CR® (carbamazepine, Novartis company) Divitabs can be
split?
Yes
No
I do not know
K4: If tablet contains a combination product; this will not affect the appropriateness or recommending for splitting or crushing or not?
Yes
No
I don't know
K5: Tegretol 400 mg CR® (carbamazepine, Novartis company) Divitabs can
be crushed?
Yes
No
I don't know

Response
Frequency (%)
N=300

212 (70.7)
88 (29.3)*
0 (0)

284(94.6)*
8 (2.7)
8 (2.7)

77 (25.7)*
197 (65.7)
26 (8.7)

75 (25)*
190(63.3)
35 (11.7)

14 (4.7)
238(79.3)*
48 (16)
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…Continue table (2)
Response
Frequency (%)
N=300

Variable
K6: Baby Aspirin cardio® (acetyl salicylic acid, Bayer company) cannot be
split or crushed because it is
Enteric coated
Extended release
I don’t know
K7: Lescol XL® (fluvastatin, Novartis company) should not be split or crushed
because it is
Enteric coated
Extended release
I don’t know
K8: Omeprazole enteric coated granule should not be crushed or split because this will:
Increase Toxicity
Inactivate active ingredient
I don’t know
K9: The administration of a crushed nifedipine XL tablet resulted in
Increase Toxicity
Inactivate active ingredient
I don’t know
K10: Pancreatin tablet should not be split or crushed because this will
Increase Toxicity
Inactivate active ingredient
I don’t know
K11: Antineoplastic agent should not be split or crushed because:
This will inactivate active ingredient
These agents may expose careers or health care professionals to health risks
I don’t know
K12: Nifedipine coated tablet should not be crushed because
The drug is highly light sensitive
Increase conc. and toxicity
I don’t know
K13: The administration of a split or crushed enteric coated sulphasalazine
tablet resulted in
Increase the serum concentration and lead to toxicity
The drug is being release too early
I don’t know
K14: Alendronate drug should not be crushed because
This will inactivate active ingredient
Due to risk of esophageal irritation
I don’t know
*was used for correct answer

Attitudes of the respondents toward crushing or splitting OSDFs
Data on respondents’ attitude toward
crushing or splitting OSDFs are found in Table 3. In general, 28.3% of the pharmacists
thought that splitting tablets is a useful way
to reduce medication costs. In response to the
question of whether physicians should prescribe split tablets as often as possible to reduce medication costs, the viewpoint of al-

261(87)*
17 (5.7)
22 (7.3)

25 (4.5)
210(38.2)*
65 (11.8)

75 (25)
190(63.3)*
35 (11.7)
188(62.6)*
49 (16.3)
63 (21)
46 (15.3)
182(60.7)*
72 (24)
46 (15.4)
166(55.5)*
87 (29)
81 (27)*
133 (44.5)
85 (28.4%)

20 (6.7)
241(80.3)*
39 (13)
32 (10.7)
221(74.2)*
45 (15.1)

most 90.7% of the pharmacists disagreed
with this idea. Most (95.6%) of the pharmacists agreed that sometimes it is difficult to
break tablets because they are small or hard.
A93.7 positive response was reported by the
pharmacists when they were asked whether
sometimes even scored tablets cannot be divided into equal parts. Only 3.5% of the
pharmacists supported the idea that all tablets
can be split or crushed if required. Nearly
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61% of the pharmacists agreed that somepackage leaflets. Thirty-three percent of
times they are not sure whether tablets are
pharmacists in this study didn’t ask experts
indeed suitable for splitting or crushing. With
about how to split tablets best. Finally, over
regard to the information about splitting or
57.6% of the pharmacists thought that splitcrushing OSDFs, 44% of the pharmacists
ting or crushing OSDFs is part of the doctor’s
expect to find information about this in the
role or responsibility.
Table (3) Responses to questions regarding attitudes of pharmacists toward crushing or splitting
oral solid dosage forms (OSDFs).
Response
Variable
Frequency (%)N=300
A1: Tablet splitting is a useful way to reduce medication costs
Yes
85 (28.3)
No
203 (67.7) ®
I don’t know
12 (4)
A2: To reduce medication costs physician should prescribe
split tablets as often as possible.
Yes
15 (5)
No
272 (90.7) ®
I don’t know
13 (4.3)
A3: Sometimes it is difficult to break tablets (e.g. because they
are very small or hard)
Yes
286 (95.6)+
No
4 (1.3)
I don’t know
9 (3.1)
A4: Sometimes even scored tablets cannot be divided into
equal part
281 (93.7)+
Yes
16 (5.3)
No
3 (1)
I don’t know
A5: If required, all tablets may be split or crushed
Yes
19 (6.3)
No
266 (88.7)®
I don’t know
15 (5)
A6: Sometimes I am not sure whether tablets are indeed suitable for splitting or crushing.
Yes
183 (61.2)
No
101(33.8)®
I don’t know
15 (5)
A7: If tablets are not suitable for splitting or crushing, I expect to find this information in the package leaflet.
Yes
132 (44)+
No
158 (52.7)
I don’t know
10 (3.3)
A8: I have ever been asked expert on how to split tablets best
Yes
172 (57.3)
No
99 (33)®
I don’t know
29 (9.7)
A9: I think that modifying the dosage form is part of the doctor’s role or responsibility
Yes
173 (57.6)+
No
107 (35.6)
I don’t know
20 (6.7)
® was used for correct negative answer
+ was used for correct positive answer
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Practices of the respondents toward crushing or splitting OSDFs
Data on respondents’ practice toward
crushing or splitting OSDFs are found in Table 4. In general, around 15% of the pharmacists in the study had split or crushed entericcoated or sustained-release OSDFs such as
baby aspirin cardio, Tegretol CR®, Pentasa®
etc. Around 95% of the pharmacists didn’t
receive training in drug stability after splitting or crushing OSDFs. As far as encourag-

ing pill splitting as a way to help patients
save money is concerned, 14.7% of the
pharmacists agreed with this statement.
When the pharmacists were asked how often
they split tablets as a way to obtain the desired dose, only 7.7% of them answered daily, 26% weekly, 39.3% monthly and 27%
didn’t split tablets. Finally, when the pharmacists were asked how often they crushed
tablets, only 3.6% of them answered daily,
4.3% weekly, 22.3% monthly and 69.6%
didn’t crush tablets.

Table (4) Responses to questions regarding practices of pharmacists toward crushing or splitting
oral solid dosage forms (OSDFs).
Variable
P1: Have you encourage pill splitting as a way to help patient save
money
Yes
No

Response Frequency
(%)N=300
44 (14.7)
256 (85.3)

P2: Have you split or crush enteric coated tablet like Baby aspirin or sustained release like ( TegretolCR; AdizemCD; Osmo-Adalat; Pentasa) ®?

Yes
No

48 (15)
252 (85)

P3: Have you received training in drug stability after splitting or crushing
OSDFs?

14 (4.7%)
Yes
286 (95.3%)
No
P4: How often have you split tablets as a way to reach the desired
dose?
23 (7.7)
Daily
78 (26)
Weekly
118 (39.3)
Monthly
81 (27)
Non
P5: How often have you done tablet crushing?
Daily
11 (3.6)
Weekly
13 (4.3)
Monthly
67 (22.3)
Non
209 (69.6)
non-practice. There was no significant differKnowledge, attitude and practice scores
ence between practice and non-practice reamong pharmacists
spondents regarding attitude score (p-value
The reported knowledge score as meas0.67). The reported knowledge score as
ured by mean scores value and attitude score
measured by mean score value for practice
were 8.7 ± 2.7 and 6.4 ± 1.4, respectively.
respondents was 9.4 ±2.9 vs. 8.6 ±2.6 for
There was a significant modest positive cornon-practice. There was a significant differrelation (r=0.18, p=0.002) between the attience between practice and non-practice retude and knowledge scores. The reported attispondents regarding knowledge score
tude score as measured by mean score value
(p=0.037).
for practice respondents (i.e. who crushed or
split OSDFs) was 6.3 ±1.4 vs. 6.3 ± 1.4 for
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Knowledge score among pharmacists

only (Kruskal-Wallis test; p<0.05). There
was no significant association between the
five demographic variables of gender, education level (Mann-Whitney test, p>0.05),
graduation institute, place of work, specialty
(Kruskal-Wallis test; p>0.05) and the
knowledge of pharmacists about crushing or
splitting OSDFs. Pharmacists aged more than
60 years old were associated with a high median score of knowledge.

The median knowledge score among
pharmacists was 9 (interquartile range: 7–
11). Nearly two-thirds of respondents
(67.3%) had a good level of knowledge (a
total knowledge score 8–14) and 32.7% of
respondents had a poor level of knowledge.
As shown in Table 5, a significant difference
in the knowledge of pharmacists toward
crushing or splitting OSDFs was found
among participant groups according to age
Table )5(: Association of socio-demographic with pharmacists’ knowledge score.
Variable
Graduation institute
Local institute
Arab institute
Others
Gender
Male
female
Place of work
Hospital
Primary care
General pharmacy
Age category Years
20-29
30-39
40-49
50-59
≤60
Educational level
Bachelor of Science
Master of Science
Specialty
General pharmacy
Clinical pharmacy
Pharmaceutics
a
b

Pharmacists
Frequency
(%) N=300

Knowledge score
Median
(interquartile range)

p- value

237 (79)
43 (14.3)
20 (6.7)

10(7-11)
8(7-10)
9(6-10)

0.096a

87 (29)
213 (71)

10(7-11)
9(7-11)

0.441b

90 (30)
22 (7.33)
188 (62.6)

10(6-11)
8(7-10)
9(7-11)

0.382a

169(56.14)
89(29.5)
19(6.31)
17(5.64)
7(2.32)

10(7-11)
9(7-10)
10(6-10)
8(5-9)
11(6-11)

0.048a

261 (87)
39 (13)

9(7-11)
10(7-11)

281 (93.7)
15 (5)
4 (1.3)

9(7-11)
10(9-11)
10(7.75-11.5)

0.551b

0.468a

Statistical significance of differences calculated using the Kruskal-Wallis test
Statistical significance of differences calculated using the Mann-Whitney U test

Attitude scores among pharmacists
The median attitude score among pharmacists was 6 (interquartile range: 5–7).
More than two-thirds of pharmacists (69%)
had a good attitude (a total score of 6–9
points) and 31% of pharmacists had a poor
attitude (a total score of 0–5). As shown in
Table 6, a significant difference in the attitudes of pharmacists toward crushing or splitting OSDFs was found among participant
groups according to specialty only (Kruskal-

Wallis test; p<0.05) There was no significant
association between the five demographic
variables (gender, education level (MannWhitney test, p>0.05), graduation institute,
age and place of work (Kruskal-Wallis test;
p>0.05) and the attitudes of pharmacists toward crushing or splitting OSDFs. Pharmaceutics specialist pharmacists were associated
with a higher median score of attitude than
general and clinical pharmacists.
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Table )6(: Association of socio-demographic with pharmacists’ attitudes score.
Variable

Pharmacists
Frequency(%) N=300

Attitudes score Median
(interquartile range)

Graduation institute
Local institute
237 (79)
6(5-7)
Arab institute
43 (14.3)
7(6-8)
Others
20 (6.7)
6(5-8)
Gender
Male
87 (29)
6(5-8)
Female
213 (71%)
6(5-7)
Place of work
Hospital
90 (30)
6(5-8)
Primary care
22 (7.33)
6(5-7)
General pharmacy
188 (62.6)
6(5-7)
Age category
20-29
169(56.14)
6(5-7)
30-39
89(29.5)
7(5-8)
40-49
19(6.31)
7(5-7)
50-59
17(5.64)
6(5-8)
≤60
7(2.32)
6(5-7)
Educational level
Bachelor of Science
261 (87)
6(5-7)
Master of Science
39 (13)
6(5-8)
Specialty
General pharmacy
281 (93.7)
6(5-7)
Clinical pharmacy
15 (5)
5(5-6)
Pharmaceutics
4 (1.3)
8(7.25-8.75)
a
Statistical significance of differences calculated using the Kruskal-Wallis test
b
Statistical significance of differences calculated using the Mann-Whitney U test

P value
0.149a

0.931b

0.807a

0.165a

0.281b

0.004a

tion between the five demographic variables
Practices among pharmacists
(gender, education level, graduation institute,
The number of pharmacists with good
specialty and place of work (p>0.05) and the
practice who didn’t crush or split entericpractice of pharmacists toward crushing or
coated or sustained-release OSDFs was 251
splitting enteric-coated or sustained-release
(83.7%). As shown in Table 7, a significant
OSDFs. The study found that the age categodifference in the practice of pharmacists tory from 20 to 29 years was associated with
ward crushing or splitting enteric-coated or
the highest frequency of good practice value
sustained-release OSDFs was found among
among pharmacists.
participant groups according to age only
(p<0.05). There was no significant associaTable )7(: Association of socio-demographic with pharmacists’ practice frequency total scores.
Variable
Graduation institute
Local institute
Arab institute
Others
Gender
Male
female
Place of work
Hospital
Primary care
General pharmacy

Total Pharmacy
Frequency N=300(%)

Yes
Frequency(%)

No
Frequency(%)

237 (79)
43 (14.3)
20 (6.7)

42(85.7)
7(14.3)
0(0)

184(77.6)
34(14.3)
19(8)

87(29)
213(71)

15(30.6)
34(69.4%)

72(28.7)
179(71.3)

91(30.3)
22(7.3)
187(62.3)

14(28.6)
7(14.3)
28(57.1)

77(30.7)
15(6)
159(63.3)

P value

0.076
0.786

0.773
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Variable
Age category
20-29
30-39
40-49
50-59
≤60
Educational level
Bachelor of Science
Master of Science
Specialty
General pharmacy
Clinical pharmacy
Pharmaceutics

… continue table (7)
No
P value
Frequency(%)

Total Pharmacy
Frequency N=300(%)

Yes
Frequency(%)

168(56)
89(29.7)
19(6.3)
17(5.7)
7(2.3)

34(69.4)
15(30.6)
0(0)
0(0)
0(0)

134(53.4)
74(29.5)
19(7.6)
17(6.8)
7(2.8)

261(87)
39(13)

45(91.8)
4(8.2)

216(86.1)
35(13.9)

281(93.7)
15(5)
4(1.3)

47(95.5)
0(0)
2(4.1)

234(93.2)
15(6)
2(0.8)

DISCUSSION
This study identifies the current
knowledge, attitudes and practice of healthcare practitioners regarding splitting or
crushing OSDFs and awareness about its
safety and therapeutic implications. It also
identifies the demographic characteristics
associated with particular knowledge, attitudes and practices and highlights the gaps in
public knowledge about this subject. In relation to this issue, pharmacists are often the
first point of contact for patients in the community. Pharmacists have a huge role to play
in giving information to the public about how
best to split or crush OSDFs. To fulfill this
aim they should have excellent medication
knowledge in all aspects of this subject.
However, there is little research on pharmacists’ experiences, and knowledge about oral
dosage forms [24-27]. No research has directly focused on attitudes, knowledge and
practice of pharmacists toward splitting or
crushing OSDFs.
Previous related studies on the same subject in the region were not available or found.
In fact, to our knowledge this study is the
first one to be conducted in our region. This
study was conducted among 300 pharmacists
to investigate their knowledge, attitudes and
practices regarding splitting or crushing
OSDFs. The study results revealed that the
vast majority of the respondents were females. This is compatible with the statistics
of the Palestinian Ministry of Health (2008),
which estimated that most of the pharmacists

0.03

0.272

0.903

in the West Bank were females. Nearly twothirds of pharmacists had a good level of
knowledge. This result can be justified since
the curriculum of pharmacy includes courses
that focus on pharmaceutical technology
which deals with modified release dosage
forms. We didn’t find any study similar to
ours regarding the knowledge of pharmacists,
thus we are unable to discuss this in the light
of other results. However, studies performed
among different subjects, such as a study in
the UK that was conducted to investigate the
knowledge of UK hospital pharmacists regarding adverse drug reaction reporting,
showed that pharmacists have a reasonable
knowledge about spontaneous adverse drug
reaction reporting schemes [28]. Australian
study aimed to observe medication solid dosage form modification in aged care facilities
(ACFs), and assess staff levels of selfperceived knowledge of medication modification and the types of resources available to
them. Authors found that improved staff
training is needed to reduce the observed
high incidence of inappropriate medication
crushing[13].
The absence of ongoing pharmacy education creates negativity regarding their role
in educating the public. Many studies show
that the public trusts information provided by
pharmacists. A study carried out in the West
Bank found that the public has a good perception of community pharmacists [29]. Another study conducted in the West Bank
showed that 30% of pregnant women take
over-the-counter (OTC) drugs from commu-
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nity pharmacies and 45% use herbal medications during pregnancy [11, 30].
In 2003, a cross-sectional study was carried out by Jaradat and Sweileh to describe
community pharmacy practice in Palestine.
They found that OTC sales of many prescription medications were common and unregulated. It also shows that the substitution of
prescribed medications was widespread [31].
Another study was conducted by the same
authors to determine the sources and needs of
drug information for community pharmacies
in Palestine. The authors concluded that few
information sources were available for community pharmacies, and this was not sufficient for pharmacists to provide patients with
appropriate drug information [31]. Australian
study aimed to observe medication solid dosage form modification in aged care facilities,
and assess staff levels of self-perceived
knowledge of medication modification and
the types of resources available to them. Authors found that improved staff training is
needed to reduce the observed high incidence
of inappropriate medication crushing [13].
Out of 300 pharmacists, around one third
of the respondents could differentiate between extended-release and enteric-coated
preparations. However, a study conducted by
Mafiana et al. [21] found that only 38% of
nurses could correctly indicate how they
would recognize sustained formulations. This
showed that there is a shortage of ongoing
education after graduation. On the other
hand, the respondents were not well informed
about the effect of more than one active ingredient in the same tablet on splitting
OSDFs: only 25% of the participants knew
that combination products in the same tablet
will not affect the appropriateness for splitting or crushing OSDFs. Respondents were
less knowledgeable about whether nifedipine-coated tablets should not be crushed
because the drug is highly light-sensitive,
which may have a negative impact on drug
stability. This is very dangerous because
most pharmacists are not aware of this problem. Among health-care practitioners, most
pharmacists were not knowledgeable about
the changes that happen when crushing or
splitting Tegretol® 400 mg GR, and Lescol

XL®. This is a cause for concern because
many studies have shown that adverse reactions and death have occurred due to changes
in the physical characteristics of some of
these drugs. Schier et al. [17] gave an example of a case of the death of a patient due to
the administration of crushed controlledrelease nifedipine with labetalol. The administration of crushed controlled-release nifedipine resulted in severe patient hypotension,
and the concurrent administration of labetalol
prevented a compensatory heart rate increase
and this led to death [17]. Furthermore, a
study by Cornish reported on death as a result
of respiratory depression in a patient due to
the administration of crushed sustainedrelease codeine in addition to the loss of efficacy of crushed enteric-coated omeprazole
[19]. According to our study, in addition to
these findings from literature there is a need
for the scope in teaching to improve pharmacists’ knowledge in this respect.
Tablet splitting and crushing is one of
many ways used by health practitioners to
offer medications in the wanted dose. Recently, researchers have been showing increased interest in this field, especially the
administration of crushed drugs for patients
with swallowing difficulties [11, 18, 22, 3235]. Patients who are unable to swallow, because of debilitating problems, need a feeding tube for nutrition or the administration of
drugs. There is little information about this
issue, and it is associated with a risk of toxicity, occlusion and decreased efficacy. Accordingly, the health practitioner must find
the best way in order to administer drugs to
patients through a feeding tube.
In 2003, the British Association for Parenteral and Enteral Nutrition (BAPEN) published guidelines on how to administer drugs
via a feeding tube, which include: (i) try to
use an alternative route instead of an oral
route such as injection or discontinue the
administration of the drug temporarily or
switch to another drug that has the same effect and is available through another oral
dosage form [11]; (ii) when no alternative
route or drug is available, use liquid or dispersible tablets, and when the formulation
has to be changed, the dose equivalencies
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must be taken into consideration; (iii) if tablets or capsules must be used, the properties
of the formulation must be taken into consideration [11]; (iv) to avoid drug/food interaction, the medicine must be administered between eating; and (v) flushing techniques
must be correct to avoid tube closure.
Issues related to swallowing difficulties
would be mentioned; if there is no alternative
route for administration, the solid dosage
form is considered [32]. Sometimes unlicensed drug use occurs. Crushed tablets may
cause closure of the feeding tube, which may
result in death or trauma to the patient. When
OSDFs are crushed it must be taken in to
consideration that some formulations should
not be crushed or opened such as unscored
tablets, some film- and sugar-coated tablets,
enteric- or protective-coated tablets, sustained-release preparations, sustained-release
granules, some microencapsulated drugs,
buccal and bitter-tasting tablets.
Our study illustrated that two-thirds of
pharmacists agreed that tablet splitting was
not a useful way to reduce medication costs,
didn’t believe that physicians should prescribe split tablets as often as possible to reduce medication costs, believed that sometimes it is difficult to break tablets because
they are small or hard, and that sometimes
even scored tablets cannot be split into two
equal parts, and don’t think that all tablets
can be split if required. A study conducted by
Quinzler et al. [20] showed that splitting tablets in primary care centers is a frequent
event due to economic considerations. In the
same study nearly 1% of all tablets that were
divided could not be fragmented or disintegrated.
Nearly half of the participants agreed
that they are not sure whether tablets are indeed suitable for splitting or crushing, that
they have never asked an expert how to split
tablets best, and that they expect to find information in the package leaflet if tablets are
not suitable for splitting or crushing. A study
conducted by Al-Ramahi et al. [36] to explore the attitude of the Palestinian public
and health-care professionals towards patient
package inserts (PPIs) found that a high per-

centage of consumers always read the PPIs.
Authors also found that 74.0% of consumers
and 83.7% of health-care professionals said
that the information in the PPIs needs to be
improved. It is clear that drug companies
should improve the pharmacological and
pharmaceutical contents in PPIs [36].In fact,
these recommendations may be useful in this
regard, since it may be helpful for patients
and healthcare providers about right way to
conduct this practice.
In general, around 15% of the pharmacists have split or crushed enteric-coated or
sustained-release OSDFs, which means that
part of pharmacists used this wrong practice,
and this may be the result of the lack of
knowledge among pharmacists or as a result
of physician orders. We didn’t find any study
similar to ours among pharmacists, thus we
are unable to discuss this in the light of other
results. A retrospective cohort study by Chiayu et al. [23] found that there were 1252 incidents of inappropriate pill splitting by doctors (1%) among 124,300 prescriptions with
special oral formulations. A study conducted
by Hanssens et al. [16] in Qatar found that
the proportion of nurses knowing about
OSDFs that should not be crushed after two
days’ training has increased from 0% to 30%.
This indicates without doubt the importance
of training for pharmacists in addition to
launch clinical pharmacy counseling to reduce inappropriate pill splitting and crushing,
which would contribute to positive patient
outcomes [37, 38]. This may raise the question about the need of a multidiscipline
course with aim to teach and train students in
pharmacy, nursing and medicine about common health care practices.
Nearly 73% of pharmacists split tablets,
while 30.2% of pharmacists crushed tablets.
More than two-thirds didn’t encourage pill
splitting to save money. Similar to what has
been found in literature, crushing or splitting
OSDFs was a common practice. A study by
Nissen et al. [39] found that among nurses
who administered medication in a hospital in
Australia, 75% crushed tablets.
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Strengths and limitations of the study
This study is considered the first in Palestine to measure the knowledge, attitudes
and practices of health-care practitioners regarding
crushing
and/or
splitting
OSDFs.Previous research across the world
produced a few studies concerning some
parts of this issue. The main limitation of this
study is that pharmacists were drawn from a
convenience sample therefore; our findings
cannot be generalised. Finally, this crosssectional study was only designed to identify
associated risk factors; it cannot assess causality.
CONCLUSIONS
In conclusion, the study found that
pharmacists had good knowledge about splitting or crushing OSDFs, although this practice is common among pharmacists. The
study provided information about special
formulations and classes of drugs that must
not be split or crushed. Pharmacists must cooperate with a view to improve pharmaceutical information about these practices. This
study raises the requirement of continuing
education programs for pharmacists about
this important subject. Moreover, the obtained results indicate the importance of including a course for pharmacy students with
the aim of improving their knowledge in
many pharmaceutical, clinical and toxicological heath care disciplines in order to minimize potential medication or practice errors
during their future carriers. Additionally,
preparing an information system compiled
using up to-date dedicated lists that contain
information on crushing, splitting and suspending medicines.
FUNDING: None.
COMPETING INTERESTS
The authors declare that they have no
competing interests.
Authors’ contributions
YA collected the data and wrote the first
draft of the manuscript, SZ contributed to the
study design, data analysis, interpretation,
data analysis, writing and revision. AZ contributed to study design and to the final draft

of the paper. All authors read and approved
the final manuscript.
ACKNOWLEDGMENTS
The research team would like to thank
all pharmacists who agreed to complete the
survey. Furthermore, the authors would like
to express many thanks and gratitude to AnNajah National University and the Palestinian Ministry of Health for their help and ethical approval to conduct this study.
REFERENCES
1) Zaid AN, Al-Ramahi R, Shahed Q, Saleh
B, Elaraj J. Determinants and frequency
of pharmaceutical compounding in
pharmacy practice in Palestine. Int J
Pharm Pract. 2012;20(1):9-14.
2) Bachynsky J, Wiens C, Melnychuk K.
The practice of splitting tablets: cost and
therapeutic
aspects.
Pharmacoeconomics. 2002;20(5):33946.
3) Green G, Berg C, Polli J, Berends DM.
Pharmacopeial standards for the
subdivision characteristics of scored
tablets.
Pharmacopeial
Forum.
2009;35:1598-603.
4) Fawell NG, Cookson TL, Scranton SS.
Relationship between tablet splitting and
compliance, drug acquisition cost, and
patient acceptance. Am J Health Syst
Pharm. 1999;56(24):2542-5.
5) Duncan MC, Castle SS, Streetman DS.
Effect of tablet splitting on serum
cholesterol
concentrations.
Ann
Pharmacother. 2002;36(2):205-9.
6) Cohen JS. Ways to minimize adverse
drug reactions. Individualized doses and
common sense are key. Postgrad Med.
1999;106(3):163-8, 71-2.
7) van Santen E, Barends DM, Frijlink
HW. Breaking of scored tablets: a
review. Eur J Pharm Biopharm.
2002;53(2):139-45.
8) Gill D, Spain M, Edlund BJ. Crushing or
splitting medications: unrecognized
hazards. J Gerontol Nurs. 2012;38(1):812.

Palestinian Medical and Pharmaceutical Journal (PMPJ). 2019; 4(1): 11-26 ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ

Abdel Naser Zaid, et al  ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ25

9) Root T, Tomlin S, D. E. Pharmaceutical
Issues when crushing, opening or
splitting oral dosage forms. Royal
pharmaceutical
society.
2011.
http://www.medicinesmanagementstoke.
nhs.uk/documents/RPS_Pharmaceutical_
Issues_when_Crushing_Opening_Splitti
ng_sdosageforms_june_2011.pdf.
Accessed July 23 2013.

release nifedipine. Ann Pharmacother.
2003;37(10):1420-3.
18) Quinzler R, Schmitt SP, Pritsch M,
Kaltschmidt J, Haefeli WE. Substantial
reduction of inappropriate tablet splitting
with computerised decision support: a
prospective intervention study assessing
potential benefit and harm. BMC Med
Inform Decis Mak. 2009;9:30.

10) Mitchell JF. Oral dosage forms that
should not be crushed. Institut for safe
medication
and
practice.
2013.
http://www.ismp.org/tools/donotcrush.pd
f. Accessed August 18 2013.

19) Cornish P. "Avoid the crush": hazards of
medication administration in patients
with dysphagia or a feeding tube. CMAJ.
2005;172(7):871-2.

11) Bowman C. Administration of drugs to
patients with swallowing difficulties. J
Malta
College
Pharm
Pract.
2007(12):42-5.

20) Quinzler R, Gasse C, Schneider A,
Kaufmann-Kolle P, Szecsenyi J, Haefeli
WE. The frequency of inappropriate
tablet splitting in primary care. Eur J
Clin Pharmacol. 2006;62(12):1065-73.

12) Akram G, Mullen AB. Paediatric nurses'
knowledge and practice of mixing
medication into foodstuff. Int J Pharm
Pract. 2012;20(3):191-8.
13) Mercovich N, Kyle GJ, Naunton M. Safe
to crush? A pilot study into solid dosage
form modification in aged care.
Australas J Ageing. 2014;33(3):180-4.
14) Ministry of Health, Palestinian Health
Information Center. Health Report Mid
Year 2013. 2013.
http://www.moh.ps/attach/546.pdf.
Accessed September 16 2014.
15) Sweileh WM, Zyoud SeH, Al-Haddad
MS. Pharmacy Practice in Palestine. In:
Fathelrahman AI, Ibrahim MIM,
Wertheimer AI, editors. Pharmacy
Practice in Developing Countries.
Boston: Academic Press; 2016. p. 25366.
16) Hanssens Y, Woods D, Alsulaiti A,
Adheir F, Al-Meer N, Obaidan N.
Improving oral medicine administration
in patients with swallowing problems
and feeding tubes. Ann Pharmacother.
2006;40(12):2142-7.
17) Schier JG, Howland MA, Hoffman RS,
Nelson LS. Fatality from administration
of labetalol and crushed extended-

21) Mafiana RN, Tagi A, Al-Zakwani I.
Evaluation of nurses’ knowledge of oral
solid dosage forms that should not be
crushed at a university hospital in Oman.
J Pharmaceutical Health Services Res.
2013;5(1):49-53.
22) Morris H. Administering drugs to
patients with swallowing difficulties.
Nurs Times. 2005;101(39):28-30.
23) Chia-yu C, Chia-chen H, Shu-chiung c,
Chin-chin H, Chia-lin C, Min-shan W et
al. Association between Physician
Specialty and Risk of Prescribing
Inappropriate Pill Splitting. PloS one.
2013;8(7):70-113.
24) Zaid AN. Attitude and perception of
patients and health care practitioners
toward oral sustained release dosage
forms in Palestine. Saudi Pharm J.
2010;18(4):251-6.
25) Nguyen T-M-U, Lau ET, Steadman KJ,
Cichero JA, Dingle K, Nissen L.
Pharmacist, general practitioner, and
nurse perceptions, experiences, and
knowledge of medication dosage form
modification. Integ Pharm Res Pract.
2014;3:1-9.
26) Lau ET, Steadman KJ, Mak M, Cichero
JA, Nissen LM. Prevalence of
swallowing difficulties and medication

 ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــPalestinian Medical and Pharmaceutical Journal (PMPJ). 2019; 4(1): 11-26

26 “ ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــKnowledge, Attitudes, and Practices of Pharmacists Toward Splitting or ……”

modification in customers of community
pharmacists. J Pharm Pract Res
2015;45(1):18-23.
27) Abbott R, Edwards S, Whelan M,
Edwards J, Dranitsaris G. Are
community pharmacists equipped to
ensure the safe use of oral anticancer
therapy in the community setting?
Results of a cross-country survey of
community pharmacists in Canada. J
Oncol Pharm Pract. 2014;20(1):29-39.
28) Green CF, Mottram DR, Rowe PH,
Pirmohamed
M.
Attitudes
and
knowledge of hospital pharmacists to
adverse drug reaction reporting. Br J
Clin Pharmacol. 2008;51(1):81-6.
29) Khdour MR, Hallak HO. Societal
perspectives on community pharmacy
services in West Bank - Palestine. Pharm
Pract (Granada). 2012;10(1):17-24.
30) Sawalha
AF.
Consumption
of
prescription
and
non-prescription
medications by pregnant women. Islamic
Univ J. 2007;2(15):41-57.
31) Jaradat N, Sweileh W. A descriptive
study of community pharmacy practice
in Palestine: Analysis and future look.
An-Najah Univ J Res (N Sc).
2003;17(2):287-300.
32) Hansen DL, Tulinius D, Hansen EH.
Adolescents' struggles with swallowing
tablets: barriers, strategies and learning.
Pharm World Sci. 2008;30(1):65-9.
33) Kelly J, D'Cruz G, Wright D. Patients
with dysphagia: experiences of taking

medication. J Adv Nurs. 2010;66(1):8291.
34) Stegemann S, Gosch M, Breitkreutz J.
Swallowing dysfunction and dysphagia
is an unrecognized challenge for oral
drug therapy. Int J Pharm. 2012;430(12):197-206.
35) Lohmann K, Freigofas J, Leichsenring J,
Wallenwein CM, Haefeli WE, Seidling
HM. Development and evaluation of an
algorithm to facilitate drug prescription
for inpatients with feeding tubes. Eur J
Clin Pharmacol. 2015;71(4):489-97.
36) Al-Ramahi R, Zaid AN, Kettana N,
Sweileh W, Al-Jabi D. Attitudes of
consumers and healthcare professionals
towards the patient package inserts - a
study in Palestine. Pharm Pract
(Granada). 2012;10(1):57-63.
37) Marquis J, Schneider MP, Payot V,
Cordonier AC, Bugnon O, Hersberger
KE et al. Swallowing difficulties with
oral drugs among polypharmacy patients
attending community pharmacies. Int J
Clin Pharm. 2013;35(6):1130-6.
38) Raimbault-Chupin M, Spiesser-Robelet
L, Guir V, Annweiler C, Beauchet O,
Clerc MA et al. Drug related problems
and pharmacist interventions in a
geriatric unit employing electronic
prescribing. Int J Clin Pharm.
2013;35(5):847-53.
39) Nissen L, Haywood A, Steadman K.
Solid
medication
dosage
form
modification at the bedside and in the
pharmacy of queensland hospitals. J
Pharm Pract Res 2009;39(2):129-34.

Palestinian Medical and Pharmaceutical Journal (PMPJ). 2019; 4(1): 11-26 ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ

